August 28, 2016 4:50 PM ET

Biotechnology

Company Overview of Endonovo Therapeutics, Inc.

Executive Profile

Randolph M. Johnson Ph.D.

Chief Development Officer and Executive Vice President of Clinical Development, Endonovo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 5 different industries.

65--

Background

Dr. Randolph M. Johnson, Ph.D., has been Chief Development Officer and Executive Vice President of Clinical Development at Endonovo Therapeutics, Inc. since December 2, 2014. Dr. Johnson has been Chief Development Officer and Executive Vice President of Preclinical Development at Cortexyme, Inc. since July 2015. He served as Chief of Technology Development and Vice President of Research at KAI Pharmaceuticals, Inc. He served as President and Chief Executive Officer of ...

Corporate Headquarters

6320 Canoga Avenue
Woodland Hills, California 91367

United States

Phone: 800-489-4774
Fax: 818-230-9899

Board Members Memberships

There is no Board Members Memberships data available.

Education

MA
California State University, Long Beach
BS
California State University, Long Beach
PhD
University of South Carolina School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Endonovo Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.